Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
Novartis AG said in a securities filing last week that Korean prosecutors launched a criminal investigation into allegations that “Novartis Korea utilized medical journals to provide inappropriate economic benefits to healthcare professionals.”… Continue Reading
Pharma giant Novartis AG agreed Wednesday to pay $25 million to settle charges that it violated the Foreign Corrupt Practices Act when two China-based subsidiaries bribed doctors and others to prescribe its drugs. … Continue Reading
An executive at Swiss pharma Novartis pleaded guilty in a bribery prosecution in Poland, the company has confirmed.
Poland’s anti-corruption bureau charged two women with bribery. Prosecutors said they gave a health fund official a tourist trip worth more than $1,000 in exchange for backing the sale of a particular drug, Reuters said.… Continue Reading
GlaxoSmithKline (GSK) will not be paying doctors to promote its pharmaceutical products through speeches following a corruption scandal in China that was disclosed earlier this year. It will also not make its sales force have individual sales targets any longer.… Continue Reading
Job Title: QA Compliance Analyst
Employer: Novartis Pharmaceuticals
Location: Fort Worth, Texas
Description
Preparation, assembly, critical review and submission for approval of Field Action Assessments, regulatory reporting to ensure agreed and statutory target dates .… Continue Reading
Job Title: Deputy Compliance Officer
Employer: Novartis Pharmaceuticals
Location: East Hanover, New Jersey
Description
The Deputy Compliance Officer (DCO) directly supports the VP, Ethics & Compliance (CCO/CCH) and leads assigned elements of oversight of the compliance program .… Continue Reading
Job Title: Director, Global Integrity & Compliance
Employer: Novartis Pharmaceuticals
Location: Fort Worth, Texas
Job Description
Supporting the U.S. Business Unit leaders (Surgical) in addressing strategic compliance priorities and coordinating policy establishment, training, communication, monitoring and enforcement activities .… Continue Reading
Image courtesy of GlaxoSmithKlineA police investigation in China has found that drugmaker GlaxoSmithKline’s alleged bribery of doctors ‘was coordinated by the British company and was not the work of individual employees,’ according to a report Tuesday by Reuters.… Continue Reading
Pharmas have told their sales teams to halt all activity in China to avoid being caught in the nationwide “enforcement storm,” according to the Guangdong-based Yangcheng Evening News.
“It is rumored that police in plain clothes are patrolling in hospitals; drug sales representatives will be fined 500 yuan ($81) and regional sales managers 1000 yuan ($162) once being caught in hospitals,” an unidentified sales representative told the paper.… Continue Reading
The headlines from Tuesday’s ethiXbase Monitor, a daily email of global corruption and compliance news, tell the story.
Here are the first four items:
… Continue ReadingChina: Glaxo Executive Says Changes in China to Cut Drug Prices
Published on Jul 24, 2013 03:00 am
GlaxoSmithKline Plc (GSK)’s head of emerging markets said after meeting with government officials in Beijing some employees may have broken China’s laws and pledged corporate changes that will deliver cheaper medicines.
ProPublica ran an exposé this week about big bucks for doctors who promote products for drug companies.
A Nashville psychiatrist led the pack, earning more than $1 million during the past four years for promotional talks and consulting for seven drug companies.… Continue Reading
Last week, Novartis agreed to pay a $185 million criminal fine for off-label marketing of the epilepsy drug Trileptal, and $237.5 million to resolve civil allegations over kickbacks paid to doctors to prescribe Trileptal and five other drugs.… Continue Reading
